Dionex Posts 14 Percent Jump in Q2 Revenues Behind Strong Asia-Pacific HPLC Sales

The company, which is currently being acquired by Thermo Fisher Scientific, recorded a 21-percent rise in HPLC sales driven largely by strong demand in China, said CEO Frank Whitney.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.